Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,545
  • Shares Outstanding, K 138,854
  • Annual Sales, $ 25,830 K
  • Annual Income, $ -26,560 K
  • 60-Month Beta 1.26
  • Price/Sales 3.82
  • Price/Cash Flow N/A
  • Price/Book 1.83
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.19
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/06/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7300 +3.32%
on 08/03/20
0.8446 -10.70%
on 07/24/20
unch (unch)
since 07/13/20
3-Month
0.7041 +7.12%
on 05/14/20
1.0400 -27.48%
on 06/08/20
+0.0064 (+0.86%)
since 05/13/20
52-Week
0.6000 +25.70%
on 03/12/20
2.4600 -69.34%
on 09/27/19
-1.1458 (-60.31%)
since 08/13/19

Most Recent Stories

More News
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020

Key Highlights:

XXII : 0.6800 (-2.86%)
CBD Could Help Smokers Move on From Tobacco

, /PRNewswire/ -- In recent years, CBD and hemp-derived products have seen a massive surge in popularity. Generally, most consumers use CBD products for medicinal purposes. Similarly, retailers are advertising...

TOBAF : 0.6600 (+0.03%)
TAAT.CN : 0.860 (-1.15%)
XXII : 0.6800 (-2.86%)
UVV : 44.66 (-2.10%)
MO : 42.70 (-0.61%)
PM : 78.39 (-1.63%)
CBD Offers Cigarette Smokers a New Way Out

, /PRNewswire/ -- Tobacco and nicotine addictions are still a major healthcare issues around the globe. In fact, according to data provided by the World Health Organization (WHO), the tobacco epidemic...

TAAT.CN : 0.860 (-1.15%)
BTI : 33.96 (-1.93%)
PM : 78.39 (-1.63%)
UVV : 44.66 (-2.10%)
XXII : 0.6800 (-2.86%)
Covid-19 impact on Legalized Cannabis Market Research Report 2020-2029 | Aurora Cannabis Inc., Aphria Inc., Canopy Growth Corporation, MedReleaf Corp, The Cronos Group

XXII : 0.6800 (-2.86%)
APHA : 4.61 (+2.22%)
ACB.TO : 13.34 (+2.22%)
HEMP : 0.0054 (+1.89%)
LXX.CN : 0.470 (+2.17%)
MEDFF : 18.8100 (-0.37%)
Consumers Seek Alternatives to Tobacco as Use Slows

, /PRNewswire/ -- According to the World Health Organization (WHO), the leading global risks for mortality in the world are high blood pressure (responsible for 13% of deaths globally), tobacco use (9%),...

TAAT.CN : 0.860 (-1.15%)
MO : 42.70 (-0.61%)
PM : 78.39 (-1.63%)
TPB : 29.47 (-1.67%)
XXII : 0.6800 (-2.86%)
Easing Regulations Place Psychedelic Medical Products on the Path to Growth

, /PRNewswire/ -- In just a few years, the perception about psychedelics and their possible uses has started to shift from a potentially dangerous party drug to an approachable medicinal product. For...

XXII : 0.6800 (-2.86%)
NUMI.VN : 0.265 (-1.85%)
LKYSD : 0.3330 (+17.54%)
CRON : 5.77 (-0.35%)
GTBIF : 15.2000 (+1.95%)
CWBHF : 3.5300 (+3.82%)
22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer

Mish brings extensive global executive leadership experience in the development, manufacturing and commercialization of active pharmaceutical ingredients, including cannabinoids, and related consumer products...

XXII : 0.6800 (-2.86%)
Psychedelics Begin to Command Greater Stature in the Medical Field

, /PRNewswire/ -- Psychedelic products for medical purposes have been getting more attention in recent years. Last year, the U.S. Food and Drug Administration (FDA) Johnson & Johnson's SPRAVATO™...

XXII : 0.6800 (-2.86%)
APHA : 4.61 (+2.22%)
ACB.TO : 13.34 (+2.22%)
NLBIF : 0.6150 (-6.82%)
NLB.CN : 1.000 (+12.36%)
CURA.CN : 11.690 (-0.76%)
APHA.TO : 6.12 (+2.17%)
Researchers Delve Into Psychedelics in Search of Novel Therapies

, /PRNewswire/ -- The trend of cannabis legalization in several countries is one of the key factors driving the market's growth. Additionally, the use of cannabis for medical purposes is gaining momentum...

ZYNE : 3.90 (-1.52%)
NLBIF : 0.6150 (-6.82%)
NLB.CN : 1.000 (+12.36%)
CRON : 5.77 (-0.35%)
XXII : 0.6800 (-2.86%)
Consumers Look for Therapeutic Alternatives During Stressful Times

, /PRNewswire/ -- The legal cannabis industry continues to grow around the world thanks to continuous legislative achievements in and . Specifically, legalization of medical cannabis and its decriminalization...

XXII : 0.6800 (-2.86%)
VFF : 6.02 (-1.47%)
WRHLF : 0.0850 (-2.30%)
PYX : 2.91 (unch)
XLY.VN : 0.225 (-4.26%)
VFF.TO : 7.96 (-1.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade XXII with:

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

2nd Resistance Point 0.7981
1st Resistance Point 0.7761
Last Price 0.6800
1st Support Level 0.7411
2nd Support Level 0.7281

See More

52-Week High 2.4600
Fibonacci 61.8% 1.7495
Fibonacci 50% 1.5300
Fibonacci 38.2% 1.3105
Last Price 0.6800
52-Week Low 0.6000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar